Revenue Breakdown
Composition ()
No data
Revenue Streams
Ekso Bionics Holdings Inc (EKSO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Device sales, accounting for 75.6% of total sales, equivalent to $3.12M. Other significant revenue streams include Service, support and Parts and other. Understanding this composition is critical for investors evaluating how EKSO navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Ekso Bionics Holdings Inc maintains a gross margin of 60.30%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -33.17%, while the net margin is -33.62%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively EKSO converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, EKSO competes directly with industry leaders such as IINN and XTLB. With a market capitalization of $30.14M, it holds a leading position in the sector. When comparing efficiency, EKSO's gross margin of 60.30% stands against IINN's 0.69% and XTLB's -436.56%. Such benchmarking helps identify whether Ekso Bionics Holdings Inc is trading at a premium or discount relative to its financial performance.
